Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

High Molecular Remission Rate in Pediatric Patients (pts) with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (r/r ALL) Treated with Blinatumomab: Rialto an Open-Label, Multicenter, Expanded Access Study

Franco Locatelli, Gerhard Zugmaier, Peter Bader, MD PhD, Sima Jeha, MD, Paul-Gerhardt Schlegel, MD, Jean-Pierre Bourquin, MD PhD, Rupert Handgretinger, MD PhD, Benoit Brethon, Claudia Rossig, MD, Christiane Chen-Santel, MD

Blood (2018) 132 (Supplement 1): 1375.

https://doi.org/10.1182/blood-2018-99-109855

Published: 2018

Journal Articles

AML SCT-BFM 2007: Results of the Prospective Hematopoietic Stem Cell Transplantation (HCT) Trial of the Berlin-Frankfurt-MÃ¼nster (BFM) Study Group for Children with Very High Risk Acute Myeloid Leukemia

Blood (2017) 130 (Supplement 1): 599.

https://doi.org/10.1182/blood.V130.Suppl_1.599.599

Published: 2017

Journal Articles

Functional Consequences of TCAB1 Mutations in Dyskeratosis Congenita

Sushree Sangita Sahoo, MSc., Caitlin Roake, B.S., Liliana Rindle, MD, Claudia Rössig, MD, Markus Schmugge, MD, Victor B Pastor, M.Sc., Brigitte Strahm, MD, Marena R Niewisch, MD, Gunda Ruzaike, BSc., Steven Artandi, MD PhD, Charlotte M Niemeyer, Prof, MD, Melanie Börries, MD PhD, Hauke Busch, PhD, Marcin Wlodarski, MD

Blood (2016) 128 (22): 3890.

https://doi.org/10.1182/blood.V128.22.3890.3890

Published: 2016

Journal Articles

Exchange Transfusion and Leukapheresis in Pediatric AML Patients with High Risk of Early Death for Bleeding and Leukostasis

Ursula Creutzig, MD, Claudia Rossig, MD, Michael Dworzak, MD, Arendt von Stackelberg, MD, Wilhelm Woessmann, MD, Jan Stary, Martin Zimmermann, PhD, Dirk Reinhardt, MD

Blood (2015) 126 (23): 3741.

https://doi.org/10.1182/blood.V126.23.3741.3741

Published: 2015

Journal Articles

Phase II Study on Bortezomib (BTZ) in Multiple Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (rALL): High Response Rate with a Modestly Intensive Regimen Including BTZ, Not Related to Pharmacokinetics

Blood (2015) 126 (23): 2501.

https://doi.org/10.1182/blood.V126.23.2501.2501

Published: 2015

Journal Articles

Response-Adapted Sequential Immuno-Chemotherapy of Post-Transplant Lymphoproliferative Disorders in Pediatric Solid Organ Transplant Recipients: Results from the Prospective Ped-PTLD 2005 Trial

Britta Maecker-Kolhoff, MD, Rita Beier, MD, Martin Zimmermann, PhD, Brigitte Schlegelberger, MD, Ulrich Baumann, MD, Carsten Mueller, MD, Lars Pape, MD, Alfred Reiter, MD, Claudia Rossig, MD, Stephan Schubert, MD, Burkhard Toenshoff, MD, Anne-Margret Wingen, MD, Barbara Meissner, MD, Christian Kebelmann-Betzing, MD, Guenter Henze, MD, Hans H. Kreipe, MD, Christoph Klein, MD PhD

Blood (2014) 124 (21): 4468.

https://doi.org/10.1182/blood.V124.21.4468.4468

Published: 2014

Journal Articles

Proposal of a Genetic Classifier for Risk Group Stratification in Pediatric T-Cell Lymphoblastic Lymphoma Reveals Significant Differences to T-Cell Lymphoblastic Leukemia

Bettina R. Bonn, Martin Zimmermann, PhD, Sebastian Balbach, Marius Rohde, Ilske Oschlies, Wolfram Klapper, MD, Olga Makarova, Claudia Rossig, MD, Birgit Burkhardt

Blood (2014) 124 (21): 2398.

https://doi.org/10.1182/blood.V124.21.2398.2398

Published: 2014

Journal Articles

Targeting Interleukin-2 to the Bone Marrow Stroma for Therapy of Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation

Christoph Schliemann, MD, Katrin Gutbrodt, PhD, Andrea Kerkhoff, MD, Michele Pohlen, MD, Stefanie Wiebe, MD, Gerda Silling, MD, Linus Angenendt, Torsten Kessler, MD, Rolf M Mesters, MD, Leonardo Giovannoni, PhD, Michael Schäfers, MD, Bianca Altvater, PhD, Claudia Rössig, MD, Inga Grünewald, MD, Eva Wardelmann, MD, Gabriele Köhler, MD, Dario Neri, PhD, Matthias Stelljes, MD, Wolfgang E Berdel, MD

Blood (2014) 124 (21): 980.

https://doi.org/10.1182/blood.V124.21.980.980

Published: 2014

Journal Articles

Clofarabine in Combination with High-Dose Cytarabine and Liposomal Daunorubicin in Pediatric AML: Results of a Phase 1B Combination Study By the ITCC Consortium

Christian M. Zwaan, MD PhD, Michael Dworzak, MD PhD, Thomas Klingebiel, MD, Claudia Rössig, MD, Guy Leverger, MD, Jan Stary, Evelina S. de Bont, MDPhD, Satianand Ramnarain, MSc, Yves Bertrand, MD, Benoit Brethon, MD, Brigitte Strahm, MD, Gertjan J. Kaspers, MD PhD, Dirk Reinhardt, MD PhD

Blood (2014) 124 (21): 989.

https://doi.org/10.1182/blood.V124.21.989.989

Published: 2014

Journal Articles

Control of Multidrug Resistant Pseudomonas Aeruginosa through Hospital Construction Design and Extensive Environmental and Clinical Surveillance in an Allogeneic Transplantat Unit

Annelene Kossow, MD, Frank Kipp, MD, Gerda Silling, MD, Andreas H Groll, MD, Claudia Rössig, MD, Heribert Jürgens, MD, Alexander Mellmann, MD, Helge Karch, MD, Wolfgang E Berdel, MD, Matthias Stelljes, MD

Blood (2014) 124 (21): 1137.

https://doi.org/10.1182/blood.V124.21.1137.1137

Published: 2014

Journal Articles

Vaccination - a Novel Strategy to Improve the Persistence of CD19CAR Transduced T-Cells in Relapsed Paediatric ALL: Preliminary Results from the CD19TPALL Study

Martin Pule, Sara Ghorashian, MD PhD FRCPath, Laura Clifton-Hadley, PhDBSc, Paul Smith, Soraya Saiagh, Paul Veys, FRCP,FRCPath, Nicholas Goulden, MD PhD, Gary Wright, Ettore Biagi, MD PhD, Bianca Altvater, PhD, Brigitte Dreno, MD, Kim Champion, PhD, Michelle Cummins, MD, Rachael Hough, MDBMBS,FRCP,FRCPath, Martin G. Sauer, MD, Claudia Rossig, MD, Persis Amrolia

Blood (2014) 124 (21): 383.

https://doi.org/10.1182/blood.V124.21.383.383

Published: 2014

Journal Articles

Safety and Pharmacokinetics Of Clofarabine In Combination With High-Dose Cytarabine and Liposomal Daunorubicin In Pediatric AML: Results Of a Phase 1 Combination Study By The ITCC Consortium

Christian M. Zwaan, Michael Dworzak, Thomas Klingebiel, MD, Claudia Rossig, MD, Guy Leverger, MD, Jan Stary, Evelina S. De Bont, MD, PhD, Satianand Ramnarain, MSc, Yves Bertrand, MD, Essam A Ghazaly, MD, Dirk Reinhardt

Blood (2013) 122 (21): 2693.

https://doi.org/10.1182/blood.V122.21.2693.2693

Published: 2013

Journal Articles

Outcome of Treatment for Relapsed Acute Lymphoblastic Leukemia in Children with Down Syndrome

Franziska Meyr, MD, Fabian Baumann, MD, Gabriele Escherich, MD, Georg Mann, MD, Thomas Klingebiel, MD, Andreas E Kulozik, MD, PhD, Claudia Rossig, MD, Martin Schrappe, Guenter Henze, MD, Arend von Stackelberg, MD, Johann K. Hitzler, MD

Blood (2012) 120 (21): 669.

https://doi.org/10.1182/blood.V120.21.669.669

Published: 2012

Journal Articles

Transient and Myeloid Leukemia in Children with Down Syndrome Mosaic

Alexandra Kolenova, MD, PhD, Katarina Reinhardt, PhD, Michaela Nathrath, MD, Claudia Rossig, MD, PhD, Arend von Stackelberg, MD, Christine von Neuhoff, MD, Annette Sander, MD, Peter Svec, MD, PhD, C. Michel Zwaan, MD, PhD, Ursula Creutzig, MD, PhD, Dirk Reinhardt, MD, PhD

Blood (2011) 118 (21): 2539.

https://doi.org/10.1182/blood.V118.21.2539.2539

Published: 2011

Journal Articles

Disturbed NK Cell Compartment In Human CML and Bcr-Abl Positive Mice.

Christiane I-U Chen, MD, Steffen Koschmieder, MD, Linda Kamp, BS, Bianca Altvater, PhD, Sibylle Pscherer, BS, Holden Maecker, PhD, Wolfgang E. Berdel, MD, Heribert Juergens, MD, Peter P Lee, MD, Claudia Rossig, MD

Blood (2010) 116 (21): 1207.

https://doi.org/10.1182/blood.V116.21.1207.1207

Published: 2010

Journal Articles

First Generation Chimeric Antigen Receptor Display Functional Defects In Key Signal Pathways Upon Antigen Stimulation

Johannes Duell, Sarah Lurati, Marcus Dittrich, Tanja Bedke, Martin Pule, Hermann Einsele, MD, Claudia Rossig, MD, Max S Topp

Blood (2010) 116 (21): 2088.

https://doi.org/10.1182/blood.V116.21.2088.2088

Published: 2010

Journal Articles

CD19-Redirected Cytotoxic T Cells Prevent Engraftment of Primary Human Leukemia Cells In Vivo.

Silke Landmeier, PhD, Bianca Altvater, PhD, Sibylle Pscherer, Jutta Meltzer, Josef Vormoor, MD, FRCPCH, Juan F Vera, MD, Martin Pule, MD, Marc Hotfilder, PhD, Heribert Juergens, MD, Claudia Rossig, MD

Blood (2009) 114 (22): 3025.

https://doi.org/10.1182/blood.V114.22.3025.3025

Published: 2009

Journal Articles

Is Prevention of Myeloid Leukemia Possible?.

Katarina Reinhardt, Marjolein Blink, MD, Annette Sander, Christine von Neuhoff, Katarina Boehmer, Alexandra Kolenova, Jan Stary, Denisa Mendelova, Jan-Henning Klusmann, MD, Dominik Schneider, Valerie de Haas, MD, PhD, Claudia Rossig, MD, Marry M. van den Heuvel, MD, PhD, Ursula Creutzig, MD, C. Michel Zwaan, MD, PhD, Dirk Reinhardt, MD, PhD

Blood (2009) 114 (22): 481.

https://doi.org/10.1182/blood.V114.22.481.481

Published: 2009

Journal Articles

Bone Marrow T Cell Subpopulations in Patients with Newly Diagnosed B-Cell Precursor Acute Lymphoblastic Leukemia (ALL).

Peter Brinkrolf, Silke Landmeier, PhD, Bianca Altvater, PhD, Sibylle Pscherer, Annegret Rosemann, Heribert Juergens, MD, Andreas Ranft, Claudia Rossig, MD

Blood (2007) 110 (11): 4278.

https://doi.org/10.1182/blood.V110.11.4278.4278

Published: 2007

Journal Articles

Tumor-Specific Chimeric Receptor-Mediated T Cell Activation Is Enhanced by 2B4 Signaling Via an NFκB-Independent Mechanism.

Bianca Altvater, PhD, Sibylle Pscherer, Silke Landmeier, PhD, Heribert Juergens, MD, Claudia Rossig, MD

Blood (2006) 108 (11): 5199.

https://doi.org/10.1182/blood.V108.11.5199.5199

Published: 2006

NARROW

High Molecular Remission Rate in Pediatric Patients (pts) with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (r/r ALL) Treated with Blinatumomab: Rialto an Open-Label, Multicenter, Expanded Access Study

AML SCT-BFM 2007: Results of the Prospective Hematopoietic Stem Cell Transplantation (HCT) Trial of the Berlin-Frankfurt-MÃ¼nster (BFM) Study Group for Children with Very High Risk Acute Myeloid Leukemia

Functional Consequences of TCAB1 Mutations in Dyskeratosis Congenita

Exchange Transfusion and Leukapheresis in Pediatric AML Patients with High Risk of Early Death for Bleeding and Leukostasis

Phase II Study on Bortezomib (BTZ) in Multiple Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (rALL): High Response Rate with a Modestly Intensive Regimen Including BTZ, Not Related to Pharmacokinetics

Response-Adapted Sequential Immuno-Chemotherapy of Post-Transplant Lymphoproliferative Disorders in Pediatric Solid Organ Transplant Recipients: Results from the Prospective Ped-PTLD 2005 Trial

Proposal of a Genetic Classifier for Risk Group Stratification in Pediatric T-Cell Lymphoblastic Lymphoma Reveals Significant Differences to T-Cell Lymphoblastic Leukemia

Targeting Interleukin-2 to the Bone Marrow Stroma for Therapy of Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation

Clofarabine in Combination with High-Dose Cytarabine and Liposomal Daunorubicin in Pediatric AML: Results of a Phase 1B Combination Study By the ITCC Consortium

Control of Multidrug Resistant Pseudomonas Aeruginosa through Hospital Construction Design and Extensive Environmental and Clinical Surveillance in an Allogeneic Transplantat Unit

Vaccination - a Novel Strategy to Improve the Persistence of CD19CAR Transduced T-Cells in Relapsed Paediatric ALL: Preliminary Results from the CD19TPALL Study

Safety and Pharmacokinetics Of Clofarabine In Combination With High-Dose Cytarabine and Liposomal Daunorubicin In Pediatric AML: Results Of a Phase 1 Combination Study By The ITCC Consortium

Outcome of Treatment for Relapsed Acute Lymphoblastic Leukemia in Children with Down Syndrome

Transient and Myeloid Leukemia in Children with Down Syndrome Mosaic

Disturbed NK Cell Compartment In Human CML and Bcr-Abl Positive Mice.

First Generation Chimeric Antigen Receptor Display Functional Defects In Key Signal Pathways Upon Antigen Stimulation

CD19-Redirected Cytotoxic T Cells Prevent Engraftment of Primary Human Leukemia Cells In Vivo.

Is Prevention of Myeloid Leukemia Possible?.

Bone Marrow T Cell Subpopulations in Patients with Newly Diagnosed B-Cell Precursor Acute Lymphoblastic Leukemia (ALL).

Tumor-Specific Chimeric Receptor-Mediated T Cell Activation Is Enhanced by 2B4 Signaling Via an NFκB-Independent Mechanism.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only